CEN BIOTECH INC
company.status.inactiveCIK 1653821fmd_1CSAHGHY1QCAJQV63ZC69KRGDGManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2014 to Sep 30, 2022, 32 periods
Latest annual · FY2021
Millions- Total revenues
- 1
- Operating income
- (19)
- Net income
- (19)
- Free cash flow
- (0)
Latest quarter · Q3 FY2022
Millions- Total revenues
- 0
- Operating income
- (0)
- Net income
- (0)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2018 to FY2021
- n/m
- Revenue, 5 yearsFY2016 to FY2021
- n/m
- Net income, 5 yearsFY2016 to FY2021
- n/m
CEN BIOTECH INC financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2021 | FY2020 | Change | Source |
|---|---|---|---|---|
| Revenue | $626,867 | $0 | 10-K 2022-04-14 · proof | |
| Operating income | -$19 million | -$2.5 million | 10-K 2022-04-14 · proof | |
| Net income | -$18.9 million | $14.2 million | -232.7% | 10-K 2022-04-14 · proof |
| Cash from operating activities | -$335,504 | -$340,749 | 10-K 2022-04-14 · proof | |
| Free cash flow | -$358,717 | -$340,749 | 10-K 2022-04-14 · proof | |
| Total assets | $8.4 million | $6.3 million | +33.7% | 10-K 2022-04-14 · proof |
| Total liabilities | $10.1 million | $16.3 million | -38.1% | 10-K 2022-04-14 · proof |
| Cash and cash equivalents | $193,198 | $1,908 | +10,025.7% | 10-K 2022-04-14 · proof |
- What was CEN BIOTECH INC's revenue in fiscal 2021?
- CEN BIOTECH INC reported revenue of $626,867 for fiscal 2021 (the year ended Dec 31, 2021), against $0 the year before. Source: the 10-K filed with the SEC on Apr 14, 2022. SEC
- What was CEN BIOTECH INC's operating income in fiscal 2021?
- CEN BIOTECH INC reported operating income of -$19 million for fiscal 2021 (the year ended Dec 31, 2021), against -$2.5 million the year before. Source: the 10-K filed with the SEC on Apr 14, 2022. SEC
- What was CEN BIOTECH INC's net income in fiscal 2021?
- CEN BIOTECH INC reported net income of -$18.9 million for fiscal 2021 (the year ended Dec 31, 2021), against $14.2 million the year before (-232.7%). Source: the 10-K filed with the SEC on Apr 14, 2022. SEC
- What was CEN BIOTECH INC's cash from operating activities in fiscal 2021?
- CEN BIOTECH INC reported cash from operating activities of -$335,504 for fiscal 2021 (the year ended Dec 31, 2021), against -$340,749 the year before. Source: the 10-K filed with the SEC on Apr 14, 2022. SEC
- What was CEN BIOTECH INC's free cash flow in fiscal 2021?
- CEN BIOTECH INC reported free cash flow of -$358,717 for fiscal 2021 (the year ended Dec 31, 2021), against -$340,749 the year before. Source: the 10-K filed with the SEC on Apr 14, 2022. SEC
- What are CEN BIOTECH INC's total assets?
- As of Dec 31, 2021, CEN BIOTECH INC reported total assets of $8.4 million, against $6.3 million a year earlier (+33.7%). Source: the 10-K filed with the SEC on Apr 14, 2022. SEC
- What are CEN BIOTECH INC's total liabilities?
- As of Dec 31, 2021, CEN BIOTECH INC reported total liabilities of $10.1 million, against $16.3 million a year earlier (-38.1%). Source: the 10-K filed with the SEC on Apr 14, 2022. SEC
- What are CEN BIOTECH INC's cash and cash equivalents?
- As of Dec 31, 2021, CEN BIOTECH INC reported cash and cash equivalents of $193,198, against $1,908 a year earlier (+10,025.7%). Source: the 10-K filed with the SEC on Apr 14, 2022. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1653821&period_type=annual&limit=5"Information only, not investment advice.